Physician profile
Kyle Sheppard
NPI 1679150262
$1,335.27
in general payments reported to CMS, 2019-2025
18 companies · $508 in 2025
The $508 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $50.81 · 2023: $493 · 2024: $284 · 2025: $508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,284.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $349.47 | 2023-2025 | Phasix Mesh |
| Avita Medical Americas, LLC | $152.71 | 2025 | Cohealyx, Recell, Permeaderm |
| Polynovo North America LLC | $143.18 | 2025 | Novosorb Btm |
| Tela Bio, INC. | $130.71 | 2024 | Ovitex 2s |
| Hologic Sales and Service, LLC | $115.64 | 2025 | Coolseal Generator |
| Kerecis Limited | $99.21 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Aroa Biosurgery Incorporated | $54.54 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $42.30 | 2023 | Gattex, Entyvio |
| Boston Scientific Corporation | $40.79 | 2025 | Spyglass Discover |
| Merck Sharp & Dohme LLC | $39.08 | 2022-2025 | Zerbaxa |
| Baxter Healthcare | $36.38 | 2023 | Tisseel |
| Astrazeneca Pharmaceuticals LP | $29.10 | 2023-2024 | Imfinzi, Andexxa |
| Mallinckrodt Hospital Products INC. | $19.48 | 2022 | |
| Abbvie INC. | $19.21 | 2024 | |
| Shionogi INC | $18.29 | 2023 | Fetroja |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $15.83 | 2024 | |
| Genmab U.S., INC. | $15.49 | 2024 | Epkinly |
| Avanos Medical | $13.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Sheppard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.